UNSPSC 51434300: Antihypertensive sulfonamides

Antihypertensive drugs made from a group of compounds that contain the structure SO2NH2.

UNSPSC 51434300 Antihypertensive sulfonamides, a Class code, encompasses medications supplied to state and local emergency response, public health, and pharmacy benefit programs — specifically beta-blockers and related antihypertensive agents for advanced life support and pharmacy dispensing. Recent solicitations show state and local buyers acquiring these products as part of broader emergency medical supply contracts, pharmacy benefit program sourcing initiatives, and cooperative purchasing agreements that bundle multiple generic pharmaceutical lines. The issuing bodies include municipal fire and rescue departments, state health agencies administering Medicaid and employee pharmacy benefits, and multistate cooperative purchasing alliances coordinating procurement across state and local jurisdictions. Work under this code involves supplying finished pharmaceutical doses (vials, injections) meeting FDA manufacturing compliance, maintaining minimum shelf life and expiration date requirements, arranging logistics including cold-chain delivery where required, and providing regulatory documentation such as Safety Data Sheets and compliance certifications with DSCSA and cGMP standards.

Activity spans Florida, Texas, and Minnesota with representation in cooperative purchasing networks extending to Oregon. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) for Tampa Fire Rescue, requesting 370 units of Labetalol HCI 100mg vials alongside epinephrine and adenosine products, with estimated contract value of $40,000 and a one-year term plus options for renewal and extension; the solicitation included a 5 percent SLBE bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs to inform future formal solicitation strategy, seeking vendor experience with self-insured group health plans and outcomes-based contracting models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP for Generic Multi Source Pharmaceuticals and OTC Products (due March 26, 2026) establishing multi-award contracts effective July 1, 2026, requiring vendors to distribute through three authorized wholesalers and accept a 3 percent administrative fee, with evaluation weighted 75 percent on price competitiveness and 25 percent across pricing format compliance, EDI capability, and administrative requirements.